NASDAQ:VERO Venus Concept Q2 2025 Earnings Results & Report $0.31 0.00 (0.00%) As of 11/6/2026 Venus Concept beat analyst expectations on both earnings and revenue in its Q2 2025 results, released August 14, 2025. The company reported EPS of -$8.03 versus the -$9.72 consensus estimate, while revenue of $15.69 million topped the $14.01 million estimate by $1.68 million. Research:ProfileForecast Earnings Announcement Details QuarterQ2 2025Report DateAugust 14, 2025TimeAfter Market ClosesConference Call5:00 PM ET Venus Concept EPS ResultsActual EPS-$8.03Consensus EPS -$9.72Beat/MissBeat by +$1.69One Year Ago EPSN/AEPS Beat Rate1 of last 7 quartersVenus Concept Revenue ResultsActual Revenue$15.69 millionExpected Revenue$14.01 millionBeat/MissBeat by +$1.68 millionYoY Revenue GrowthN/AConference Call ResourcesConference Call AudioConference Call TranscriptPress Release (8-K)Quarterly Report (10-Q)Company ProfilePowered by Venus Concept Q2 2025 Earnings Call TranscriptProvided by QuartrAugust 14, 2025ShareShareShare This ReportLink copied to clipboard.Key Takeaways Positive Sentiment: We delivered 15% sequential revenue growth in Q2, driven by mid‐teens increases in both U.S. and international markets, in line with prior expectations. Negative Sentiment: Total revenue declined 5% year‐over‐year, with an 18% drop internationally offsetting U.S. growth. Positive Sentiment: The definitive agreement to sell the Venus Hair business for an all-cash $20 million is expected to strengthen focus on core medical aesthetics and improve cash flow. Negative Sentiment: Gross profit fell 20% and gross margin declined to 60.1% from 71.5%, impacted by supply disruptions and adverse sales mix. Positive Sentiment: Balance sheet improvements include reducing debt to $34.3 million, exchanging $17.5 million of notes for preferred stock, and raising $3.9 million in equity proceeds. AI Generated. May Contain Errors.Conference Call Audio Live Call not available Earnings Conference CallVenus Concept Q2 202500:00 / 00:00Speed:1x1.25x1.5x2xThere are 3 speakers on the call. Speaker 200:00:00Today, ladies and gentlemen, and welcome to the second quarter 2025 earnings conference call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay. Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including those identified in the risk factors section of our most recent annual report on Form 10-K filed with the Securities and Exchange Commission. Such factors may be updated from time to time in our filings with the SEC, which are available on our website. Speaker 200:00:53We undertake no obligation to publicly update or revise our forward-looking statements as a result of new information, future events, or otherwise. This call will also include references to certain financial measures that are not calculated in accordance with generally accepted accounting principles or GAAP. We generally refer to these as non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to the most comparable measures calculated and presented in accordance with GAAP are available in our earnings press release issued today on the investor relations portion of our website. I would now like to turn the call over to Mr. Rajiv De Silva, Chief Executive Officer of Venus Concept. Please go ahead, sir. Operator00:01:39Thank you, operator, and welcome everyone to Venus Concept Inc.'s second quarter 2025 earnings conference call. I'm joined on the call today by our Chief Financial Officer, Domenic Della Penna. Let me start with an agenda of what we will cover during our prepared remarks. I will begin with a brief review of our second quarter results and operating developments in the recent months. Following that, Domenic will provide you with an in-depth review of our second quarter financial results, as well as an update on our balance sheet and financial condition. With that agenda in mind, let's get started. As detailed in our press release issued today, we delivered 15% growth on a quarter-over-quarter basis in Q2, driven by strong execution from the team in a continued challenging environment. Importantly, the sequential growth performance in the second quarter was consistent with the expectations outlined on our first quarter call. Operator00:02:46Sequential growth was driven by mid-teens growth in both the U.S. and international markets and was fueled primarily by 20% growth in total systems and subscription revenue. Second quarter revenue declined 5% on a year-over-year basis, driven by a 5% growth in sales to U.S. customers, offset by an 18% decline in international sales compared to the second quarter of 2024. Notably, year-over-year growth in the U.S. was primarily driven by double-digit growth in total systems and subscription revenue, with cash system sales increasing 23% year-over-year in that period. The company views the year-over-year results as a potential sign of revenue stabilization. The global capital equipment environment continues to present a level of uncertainty as to the timing and pace of new systems adoption across the aesthetic sector as a whole. Operator00:03:50Customer financing pressures, economic uncertainty, high interest rates, tight credit markets, and uncertainty related to proposed tariffs continue to impact customer system adoption throughout our business. While we are seeing these macro dynamics impacting adoption trends in the U.S., our international business is particularly exposed to macroeconomic headwinds, including tariffs related to impacts to distributor demand. Despite the more challenged operating environment, we are encouraged by the team's continued focus on customer engagement and support, as well as improving sales efficiency by prioritizing core products in the U.S., including BlissMax, VersaPro, and VivaMD. The team also remains highly focused on our strategic priority to transition the company to higher-quality cash revenues. Cash system sales in the U.S. represented 65% of total U.S. system sales in the second quarter, compared to 58% last year. Operator00:04:59We continue to believe that our efforts to reposition the business to prioritize cash system sales are the right strategy to enhance the company's long-term profitability profile. That said, we are also pleased to have the optionality provided by our Venus Prime program to support system adoption to our high-quality customers in a thoughtful and strategic manner. Before I turn the call over to Domenic Della Penna, I wanted to review an important strategic announcement we made in June. On June 6, we announced a definitive agreement to sell the Venus Hair business to Meta Health Group, in an all-cash transaction valued at $20 million. This transaction represents the first outcome of our evaluation of strategic alternatives to maximize shareholder value. Importantly, we believe this transaction strengthens Venus Concept Inc. Operator00:06:03by allowing us to focus on our global medical aesthetics business, which we expect will improve revenue growth, lower operating expenses, enhance the cash flow profile of the business, and accelerate the path to long-term sustainable profitability and growth. Meta Health Group was established in 2011 and in 2021 and is headquartered in Seoul, South Korea. Meta Health Group operates as a holding company that develops and manages top-tier clinic brands across various aesthetic medical fields. We believe that they are an ideal acquirer of the Venus Hair business, given their capabilities in the aesthetic medical field, including a presence in the hair transplant market, as well as their strategic investments in next-generation medical industries, including medical AI, medical robotics, and R&D that drive innovation in healthcare technology. Operator00:07:03We are committed to ensuring a smooth transition for our employees, customers, and other stakeholders, and are confident Meta Health Group will provide the strategic investment and resources needed to maximize the global addressable markets for the Artis and NeoGraft technologies. The transaction is expected to close in the third quarter of 2025, subject to the satisfaction or waiver of certain closing conditions, including an internal reorganization of the hair business into Meta Robotics LLC. In closing, we delivered solid sequential growth in Q2 and significantly improved our year-over-year decline, despite a continued challenging capital equipment environment. We made material progress towards improving our balance sheet and financial condition, which Domenic will review in detail shortly. Operator00:07:58We announced a significant strategic transaction with the sale of the Venus Hair business, which strengthens Venus Concept by allowing us to focus on our global medical aesthetics business, and the proceeds from which will further enhance our balance sheet and financial condition and provide valuable capital to fund strategic growth initiatives. Our priority remains on ensuring that we are as well positioned as possible to return to growth. We are actively working on evolving our portfolio and look forward to launching our next body device by early 2026. We believe that the increase of GLP-1 usage by consumers is an exciting catalyst for the industry and a chance for Venus to highlight the complementary benefits of our body technology, specifically skin tightening to our customers that are on weight loss medications. Operator00:08:51We are managing our cash burn through disciplined cost management and making targeted investments to support our long-term growth. We also intend to continue the ongoing evaluation of strategic alternatives to maximize shareholder value. With that, let me turn the call over to Domenic for a review of our second quarter financial results and balance sheet. Domenic? Speaker 100:09:17Thanks, Rajiv. For the avoidance of doubt, unless otherwise noted, my prepared remarks will focus on the company's reported results for the second quarter of 2025 on a GAAP basis, and all growth-related items are on a year-over-year basis. We reported total revenue of $15.7 million, down $0.9 million, or 5% year-over-year. The decrease in total revenue by region was driven by an 18% decrease year-over-year in international revenue, offset partially by a 5% increase year-over-year in U.S. revenue. The year-over-year decrease in total revenue by product category was driven by a 4% increase in lease systems revenue, offset by an 8% decrease in products systems revenue, an 8% decrease in products other revenue, and a 24% decrease in services revenue. Speaker 100:10:18The percentage of total systems revenue derived from the company's internal lease program, Venus Prime, and our legacy subscription model was approximately 37% in the second quarter of 2025, compared to 34% in the prior year period. Turning to a review of our second quarter financial results across the rest of the P&L, gross profit decreased $2.4 million, or 20%, to $9.4 million, compared to the second quarter of 2024. The decrease in gross profit is primarily attributable to the effects of customer uncertainty about economic stability, tighter third-party lending practices which negatively impacted capital equipment sales, and a decrease in revenue in our international markets driven by the exit from unprofitable direct markets, as well as the uncertainty created by international tariffs, actions, and threats. Speaker 100:11:18To a lesser extent, gross profit declines were also impacted by supply disruptions caused by the Israel-Iran conflict, impacting production at our contract manufacturer's facility in Israel. Gross margin was 60.1% of revenue, compared to 71.5% of revenue for the second quarter of 2024. The decrease in gross margin is primarily attributable to the supply disruptions noted above, resulting in an adverse sales mix due to the shortages of higher margin devices and, to a lesser extent, higher device system cost of goods sold, tracing to manufacturing overheads spread over a lower volume base. The total operating expenses increased $1 million, or 6%, to $18.5 million. Total operating expenses increased $0.2 million, or 1%, on a quarter-over-quarter basis. The modest increase in operating expense reflects our continued progress in cost containment and streamlining of our operations. Speaker 100:12:29GAAP operating loss was $9.0 million, compared to $5.6 million in the second quarter of 2024. Net interest and other expenses were $2.5 million, compared to $14.1 million in the second quarter of 2024. The year-over-year change in net interest and other expenses was driven by a $1.9 million non-cash loss on debt extinguishment, compared to $10.9 million last year, a non-cash foreign exchange gain of $0.5 million, compared to a non-cash loss of $0.8 million last year, and lower interest expense on outstanding borrowings, which totaled $1.2 million in the second quarter, compared to $2.5 million last year, void by our progress on debt extinguishment. Net loss attributable to stockholders for the second quarter of 2025 of $11.7 million, or $8.03 per share, compared to net loss of $20.0 million, or $30.93 per share for the second quarter of 2024. Speaker 100:13:44Weighted average shares outstanding for the second quarter of 2025 and 2024 gives effect for the company's 1:411 reverse stock split effective March 3, 2025. Adjusted EBITDA loss for the second quarter of 2025 of $8.8 million, compared to adjusted EBITDA loss of $4.1 million for the second quarter of 2024. As a reminder, we have provided a full reconciliation of our GAAP net loss to adjusted EBITDA loss in our earnings press release. Turning to the balance sheet, as of June 30, 2025, the company had cash and cash equivalents of $4.9 million and total debt obligations of approximately $34.3 million, compared to $4.3 million and total debt obligations of approximately $39.7 million, respectively, as of December 31, 2024. We have made significant progress towards improving our balance sheet and financial condition over the first six months of 2025. Speaker 100:14:55We announced amendments with our primary lender, Madryn Asset Management, which increased our financing capacity under our existing bridge loan facility. We continue to appreciate the support of Madryn as we continue to enhance the financial profile of the business. We exchanged a total of $17.5 million of subordinated convertible notes held by affiliates of Madryn Asset Management LP for preferred stock, including $6.5 million exchanged for 325,651 shares of its Series W preferred stock in the second quarter, and we raised gross proceeds of $3.9 million in multiple equity capital markets transactions from existing and new investors. Lastly, with respect to our financial outlook for 2025, given the company's active dialogue with existing lenders and investors, ongoing evaluation of strategic alternatives with various interested parties to maximize shareholder value, and current market conditions impacted by trade disruptions, the company is not providing full-year 2025 financial guidance at this time. Speaker 100:16:15That concludes our prepared remarks. Given international travel conflicts, we are not hosting a live Q&A session this afternoon. Please direct all follow-up questions to our investor inquiries email address, ir.venusconcept.com. Thank you for your interest in Venus Concept. Speaker 200:16:38Ladies and gentlemen, this concludes today's teleconference. You may disconnect your lines or log off the webcast at this time and enjoy the rest of your day.Read morePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Venus Concept Q2 2025 Earnings FAQ Did Venus Concept beat earnings estimates for Q2 2025? Venus Concept (NASDAQ:VERO) reported earnings of -$8.03 per share for Q2 2025, beating the consensus estimate of -$9.72. The report was announced on Thursday, August 14, 2025. What was Venus Concept's revenue for Q2 2025? Venus Concept reported revenue of $15.69 million for Q2 2025, against a consensus estimate of $14.01 million. Where can I read Venus Concept's Q2 2025 earnings call transcript? The full Venus Concept Q2 2025 earnings conference call transcript is published on this page, including prepared remarks and the analyst Q&A session, along with the participants who spoke on the call. Venus Concept Earnings HeadlinesVenus Concept Obtains Exclusive Distribution Rights for the HIRONIC Doublo 2.0 Device in US and CanadaJuly 28, 2026 | globenewswire.comVenus Concept Announces Senior Management ChangesMay 13, 2026 | globenewswire.comWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.November 22 at 1:00 AM | Porter & Company (Ad)Venus Concept Announces Completion of Common Stock Sale and Short-Form MergerApril 1, 2026 | globenewswire.comVenus Concept stock plummets after announcing Nasdaq delisting plansJanuary 21, 2026 | uk.investing.comVenus Concept to exit NASDAQ and end SEC reporting obligationsJanuary 21, 2026 | msn.comSee More Venus Concept Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Venus Concept? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Venus Concept and other key companies, straight to your email. Email Address About Venus ConceptVenus Concept (NASDAQ:VERO) is a medical technology company that develops and markets devices for aesthetic and hair-restoration procedures. Its systems are designed for use by medical and aesthetic professionals in clinics and other treatment settings. The company’s product portfolio includes technologies for skin resurfacing, hair removal, body contouring and skin tightening, as well as hair-transplant systems such as NeoGraft and ARTAS. Its devices use approaches including radiofrequency, laser and light-based energy. Based in Toronto, Canada, Venus Concept serves customers in multiple international markets through direct sales and distribution partners. The company was founded in 2009 and has focused on providing technology and related services to the global medical aesthetics industry.View Venus Concept ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 11/16 - 11/20Keysight Technologies: The Tollbooth on the Technology SuperhighwayGrowing Pains Versus Growth: Is BJ’s Wholesale Club a Buying Opportunity?Bargain Hunting: Why Off-Price Retail Is WinningZscaler Got a Boost From Palo Alto, But Now It Has to Deliver.If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel ItZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
There are 3 speakers on the call. Speaker 200:00:00Today, ladies and gentlemen, and welcome to the second quarter 2025 earnings conference call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay. Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including those identified in the risk factors section of our most recent annual report on Form 10-K filed with the Securities and Exchange Commission. Such factors may be updated from time to time in our filings with the SEC, which are available on our website. Speaker 200:00:53We undertake no obligation to publicly update or revise our forward-looking statements as a result of new information, future events, or otherwise. This call will also include references to certain financial measures that are not calculated in accordance with generally accepted accounting principles or GAAP. We generally refer to these as non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to the most comparable measures calculated and presented in accordance with GAAP are available in our earnings press release issued today on the investor relations portion of our website. I would now like to turn the call over to Mr. Rajiv De Silva, Chief Executive Officer of Venus Concept. Please go ahead, sir. Operator00:01:39Thank you, operator, and welcome everyone to Venus Concept Inc.'s second quarter 2025 earnings conference call. I'm joined on the call today by our Chief Financial Officer, Domenic Della Penna. Let me start with an agenda of what we will cover during our prepared remarks. I will begin with a brief review of our second quarter results and operating developments in the recent months. Following that, Domenic will provide you with an in-depth review of our second quarter financial results, as well as an update on our balance sheet and financial condition. With that agenda in mind, let's get started. As detailed in our press release issued today, we delivered 15% growth on a quarter-over-quarter basis in Q2, driven by strong execution from the team in a continued challenging environment. Importantly, the sequential growth performance in the second quarter was consistent with the expectations outlined on our first quarter call. Operator00:02:46Sequential growth was driven by mid-teens growth in both the U.S. and international markets and was fueled primarily by 20% growth in total systems and subscription revenue. Second quarter revenue declined 5% on a year-over-year basis, driven by a 5% growth in sales to U.S. customers, offset by an 18% decline in international sales compared to the second quarter of 2024. Notably, year-over-year growth in the U.S. was primarily driven by double-digit growth in total systems and subscription revenue, with cash system sales increasing 23% year-over-year in that period. The company views the year-over-year results as a potential sign of revenue stabilization. The global capital equipment environment continues to present a level of uncertainty as to the timing and pace of new systems adoption across the aesthetic sector as a whole. Operator00:03:50Customer financing pressures, economic uncertainty, high interest rates, tight credit markets, and uncertainty related to proposed tariffs continue to impact customer system adoption throughout our business. While we are seeing these macro dynamics impacting adoption trends in the U.S., our international business is particularly exposed to macroeconomic headwinds, including tariffs related to impacts to distributor demand. Despite the more challenged operating environment, we are encouraged by the team's continued focus on customer engagement and support, as well as improving sales efficiency by prioritizing core products in the U.S., including BlissMax, VersaPro, and VivaMD. The team also remains highly focused on our strategic priority to transition the company to higher-quality cash revenues. Cash system sales in the U.S. represented 65% of total U.S. system sales in the second quarter, compared to 58% last year. Operator00:04:59We continue to believe that our efforts to reposition the business to prioritize cash system sales are the right strategy to enhance the company's long-term profitability profile. That said, we are also pleased to have the optionality provided by our Venus Prime program to support system adoption to our high-quality customers in a thoughtful and strategic manner. Before I turn the call over to Domenic Della Penna, I wanted to review an important strategic announcement we made in June. On June 6, we announced a definitive agreement to sell the Venus Hair business to Meta Health Group, in an all-cash transaction valued at $20 million. This transaction represents the first outcome of our evaluation of strategic alternatives to maximize shareholder value. Importantly, we believe this transaction strengthens Venus Concept Inc. Operator00:06:03by allowing us to focus on our global medical aesthetics business, which we expect will improve revenue growth, lower operating expenses, enhance the cash flow profile of the business, and accelerate the path to long-term sustainable profitability and growth. Meta Health Group was established in 2011 and in 2021 and is headquartered in Seoul, South Korea. Meta Health Group operates as a holding company that develops and manages top-tier clinic brands across various aesthetic medical fields. We believe that they are an ideal acquirer of the Venus Hair business, given their capabilities in the aesthetic medical field, including a presence in the hair transplant market, as well as their strategic investments in next-generation medical industries, including medical AI, medical robotics, and R&D that drive innovation in healthcare technology. Operator00:07:03We are committed to ensuring a smooth transition for our employees, customers, and other stakeholders, and are confident Meta Health Group will provide the strategic investment and resources needed to maximize the global addressable markets for the Artis and NeoGraft technologies. The transaction is expected to close in the third quarter of 2025, subject to the satisfaction or waiver of certain closing conditions, including an internal reorganization of the hair business into Meta Robotics LLC. In closing, we delivered solid sequential growth in Q2 and significantly improved our year-over-year decline, despite a continued challenging capital equipment environment. We made material progress towards improving our balance sheet and financial condition, which Domenic will review in detail shortly. Operator00:07:58We announced a significant strategic transaction with the sale of the Venus Hair business, which strengthens Venus Concept by allowing us to focus on our global medical aesthetics business, and the proceeds from which will further enhance our balance sheet and financial condition and provide valuable capital to fund strategic growth initiatives. Our priority remains on ensuring that we are as well positioned as possible to return to growth. We are actively working on evolving our portfolio and look forward to launching our next body device by early 2026. We believe that the increase of GLP-1 usage by consumers is an exciting catalyst for the industry and a chance for Venus to highlight the complementary benefits of our body technology, specifically skin tightening to our customers that are on weight loss medications. Operator00:08:51We are managing our cash burn through disciplined cost management and making targeted investments to support our long-term growth. We also intend to continue the ongoing evaluation of strategic alternatives to maximize shareholder value. With that, let me turn the call over to Domenic for a review of our second quarter financial results and balance sheet. Domenic? Speaker 100:09:17Thanks, Rajiv. For the avoidance of doubt, unless otherwise noted, my prepared remarks will focus on the company's reported results for the second quarter of 2025 on a GAAP basis, and all growth-related items are on a year-over-year basis. We reported total revenue of $15.7 million, down $0.9 million, or 5% year-over-year. The decrease in total revenue by region was driven by an 18% decrease year-over-year in international revenue, offset partially by a 5% increase year-over-year in U.S. revenue. The year-over-year decrease in total revenue by product category was driven by a 4% increase in lease systems revenue, offset by an 8% decrease in products systems revenue, an 8% decrease in products other revenue, and a 24% decrease in services revenue. Speaker 100:10:18The percentage of total systems revenue derived from the company's internal lease program, Venus Prime, and our legacy subscription model was approximately 37% in the second quarter of 2025, compared to 34% in the prior year period. Turning to a review of our second quarter financial results across the rest of the P&L, gross profit decreased $2.4 million, or 20%, to $9.4 million, compared to the second quarter of 2024. The decrease in gross profit is primarily attributable to the effects of customer uncertainty about economic stability, tighter third-party lending practices which negatively impacted capital equipment sales, and a decrease in revenue in our international markets driven by the exit from unprofitable direct markets, as well as the uncertainty created by international tariffs, actions, and threats. Speaker 100:11:18To a lesser extent, gross profit declines were also impacted by supply disruptions caused by the Israel-Iran conflict, impacting production at our contract manufacturer's facility in Israel. Gross margin was 60.1% of revenue, compared to 71.5% of revenue for the second quarter of 2024. The decrease in gross margin is primarily attributable to the supply disruptions noted above, resulting in an adverse sales mix due to the shortages of higher margin devices and, to a lesser extent, higher device system cost of goods sold, tracing to manufacturing overheads spread over a lower volume base. The total operating expenses increased $1 million, or 6%, to $18.5 million. Total operating expenses increased $0.2 million, or 1%, on a quarter-over-quarter basis. The modest increase in operating expense reflects our continued progress in cost containment and streamlining of our operations. Speaker 100:12:29GAAP operating loss was $9.0 million, compared to $5.6 million in the second quarter of 2024. Net interest and other expenses were $2.5 million, compared to $14.1 million in the second quarter of 2024. The year-over-year change in net interest and other expenses was driven by a $1.9 million non-cash loss on debt extinguishment, compared to $10.9 million last year, a non-cash foreign exchange gain of $0.5 million, compared to a non-cash loss of $0.8 million last year, and lower interest expense on outstanding borrowings, which totaled $1.2 million in the second quarter, compared to $2.5 million last year, void by our progress on debt extinguishment. Net loss attributable to stockholders for the second quarter of 2025 of $11.7 million, or $8.03 per share, compared to net loss of $20.0 million, or $30.93 per share for the second quarter of 2024. Speaker 100:13:44Weighted average shares outstanding for the second quarter of 2025 and 2024 gives effect for the company's 1:411 reverse stock split effective March 3, 2025. Adjusted EBITDA loss for the second quarter of 2025 of $8.8 million, compared to adjusted EBITDA loss of $4.1 million for the second quarter of 2024. As a reminder, we have provided a full reconciliation of our GAAP net loss to adjusted EBITDA loss in our earnings press release. Turning to the balance sheet, as of June 30, 2025, the company had cash and cash equivalents of $4.9 million and total debt obligations of approximately $34.3 million, compared to $4.3 million and total debt obligations of approximately $39.7 million, respectively, as of December 31, 2024. We have made significant progress towards improving our balance sheet and financial condition over the first six months of 2025. Speaker 100:14:55We announced amendments with our primary lender, Madryn Asset Management, which increased our financing capacity under our existing bridge loan facility. We continue to appreciate the support of Madryn as we continue to enhance the financial profile of the business. We exchanged a total of $17.5 million of subordinated convertible notes held by affiliates of Madryn Asset Management LP for preferred stock, including $6.5 million exchanged for 325,651 shares of its Series W preferred stock in the second quarter, and we raised gross proceeds of $3.9 million in multiple equity capital markets transactions from existing and new investors. Lastly, with respect to our financial outlook for 2025, given the company's active dialogue with existing lenders and investors, ongoing evaluation of strategic alternatives with various interested parties to maximize shareholder value, and current market conditions impacted by trade disruptions, the company is not providing full-year 2025 financial guidance at this time. Speaker 100:16:15That concludes our prepared remarks. Given international travel conflicts, we are not hosting a live Q&A session this afternoon. Please direct all follow-up questions to our investor inquiries email address, ir.venusconcept.com. Thank you for your interest in Venus Concept. Speaker 200:16:38Ladies and gentlemen, this concludes today's teleconference. You may disconnect your lines or log off the webcast at this time and enjoy the rest of your day.Read morePowered by